Literature DB >> 28945950

Complexity and function of natural killer T cells with potential application to hepatic transplant survival.

Randle Ware1, Vipin Kumar1.   

Abstract

One of the major innate-like lymphocyte populations enriched in the liver consists of natural killer T (NKT) cells, which recognize self and foreign lipid antigens presented by the nonpolymorphic class I major histocompatibility complex-like molecule CD1d. NKT cells express natural killer cell markers as well as T cell receptors (TCRs) and can be classified into 2 categories: type I NKT cells use a semi-invariant TCR, whereas type II NKT cells express diverse but still limited TCRs. An emerging body of evidence points to their opposing roles in inflammation, including ischemia/reperfusion injury. Improved understanding of their roles in experimental models as well as in humans and the means by which their function can be manipulated may provide therapeutic benefit in liver diseases and in organ transplantation. Liver Transplantation 23 1589-1592 2017 AASLD.
© 2017 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28945950      PMCID: PMC6075735          DOI: 10.1002/lt.24950

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  17 in total

1.  Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a beta-linked self-glycolipid.

Authors:  Philomena Arrenberg; Ramesh Halder; Yang Dai; Igor Maricic; Vipin Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

2.  Recognition of lysophosphatidylcholine by type II NKT cells and protection from an inflammatory liver disease.

Authors:  Igor Maricic; Enrico Girardi; Dirk M Zajonc; Vipin Kumar
Journal:  J Immunol       Date:  2014-09-26       Impact factor: 5.422

Review 3.  Type II NKT cells: a distinct CD1d-restricted immune regulatory NKT cell subset.

Authors:  Suryasarathi Dasgupta; Vipin Kumar
Journal:  Immunogenetics       Date:  2016-07-12       Impact factor: 2.846

Review 4.  The autotaxin-LPA axis emerges as a novel regulator of lymphocyte homing and inflammation.

Authors:  Sara Knowlden; Steve N Georas
Journal:  J Immunol       Date:  2014-02-01       Impact factor: 5.422

Review 5.  Type II NKT Cells and Their Emerging Role in Health and Disease.

Authors:  Madhav V Dhodapkar; Vipin Kumar
Journal:  J Immunol       Date:  2017-02-01       Impact factor: 5.422

6.  Sulfatide-mediated activation of type II natural killer T cells prevents hepatic ischemic reperfusion injury in mice.

Authors:  Philomena Arrenberg; Igor Maricic; Vipin Kumar
Journal:  Gastroenterology       Date:  2010-10-13       Impact factor: 22.682

Review 7.  Natural Killer T cell obsession with self-antigens.

Authors:  Laurent Gapin; Dale I Godfrey; Jamie Rossjohn
Journal:  Curr Opin Immunol       Date:  2013-02-04       Impact factor: 7.486

8.  Type II natural killer T cells use features of both innate-like and conventional T cells to recognize sulfatide self antigens.

Authors:  Enrico Girardi; Igor Maricic; Jing Wang; Thien-Thi Mac; Pooja Iyer; Vipin Kumar; Dirk M Zajonc
Journal:  Nat Immunol       Date:  2012-07-22       Impact factor: 25.606

Review 9.  Type II NKT Cells in Inflammation, Autoimmunity, Microbial Immunity, and Cancer.

Authors:  Idania Marrero; Randle Ware; Vipin Kumar
Journal:  Front Immunol       Date:  2015-06-17       Impact factor: 7.561

10.  Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide.

Authors:  Alex Jahng; Igor Maricic; Carlos Aguilera; Susanna Cardell; Ramesh C Halder; Vipin Kumar
Journal:  J Exp Med       Date:  2004-03-29       Impact factor: 14.307

View more
  5 in total

Review 1.  The Role of CD1d and MR1 Restricted T Cells in the Liver.

Authors:  Wenyong Huang; Wenjing He; Xiaomin Shi; Xiaoshun He; Lang Dou; Yifang Gao
Journal:  Front Immunol       Date:  2018-10-30       Impact factor: 7.561

2.  Intrahepatic microbes govern liver immunity by programming NKT cells.

Authors:  Joshua C Leinwand; Bidisha Paul; Ruonan Chen; Fangxi Xu; Maria A Sierra; Madan M Paluru; Sumant Nanduri; Carolina G Alcantara; Sorin Aa Shadaloey; Fan Yang; Salma A Adam; Qianhao Li; Michelle Bandel; Inderdeep Gakhal; Lara Appiah; Yuqi Guo; Mridula Vardhan; Zia Flaminio; Emilie R Grodman; Ari Mermelstein; Wei Wang; Brian Diskin; Berk Aykut; Mohammad Khan; Gregor Werba; Smruti Pushalkar; Mia McKinstry; Zachary Kluger; Jaimie J Park; Brandon Hsieh; Kristen Dancel-Manning; Feng-Xia Liang; James S Park; Anjana Saxena; Xin Li; Neil D Theise; Deepak Saxena; George Miller
Journal:  J Clin Invest       Date:  2022-04-15       Impact factor: 19.456

3.  Abrogation of graft ischemia-reperfusion injury in ischemia-free liver transplantation.

Authors:  Zhiyong Guo; Jinghong Xu; Shanzhou Huang; Meixian Yin; Qiang Zhao; Weiqiang Ju; Dongping Wang; Ningxin Gao; Changjun Huang; Lu Yang; Maogen Chen; Zhiheng Zhang; Zebin Zhu; Linhe Wang; Caihui Zhu; Yixi Zhang; Yunhua Tang; Haitian Chen; Kunpeng Liu; Yuting Lu; Yi Ma; Anbin Hu; Yinghua Chen; Xiaofeng Zhu; Xiaoshun He
Journal:  Clin Transl Med       Date:  2022-04

Review 4.  The Human Immune Response to Cadaveric and Living Donor Liver Allografts.

Authors:  Angus Hann; Daniel-Clement Osei-Bordom; Desley A H Neil; Vincenzo Ronca; Suz Warner; M Thamara P R Perera
Journal:  Front Immunol       Date:  2020-06-22       Impact factor: 7.561

Review 5.  The Immunological Basis of Liver Allograft Rejection.

Authors:  Vincenzo Ronca; Grace Wootton; Chiara Milani; Owen Cain
Journal:  Front Immunol       Date:  2020-09-02       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.